IGM Biosciences Inc (IGMS)
$6.45 $0.05 (0.78%) 4:37 PM 07/04/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$405.49M -
Day's Range
$6.25 - $6.79 -
Volume
257,558 -
52 Week Low / High
$3.81 - $17.70 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
IGMS's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 5
- Strong Buy
- 1
- Buy
- 4
- Hold
- 0
- Sell
- 0
- Strong Sell
- $22.09
- Target Price
Company News
-
IGM Bio (IGMS) Stock Rallies 142% in 3 Months: Here's Why — Jan 16th, 2024
IGM Biosciences IGMS, a clinical-stage company, is developing a pipeline of Immunoglobin M (IgM) antibody-based candidates to treat patients with cancer and autoimmune and inflammatory diseases. The company believes that an IgM has the potential to become a better antibody medicine, given...
Similar Stocks
No similar stocks found.
|
$